Search research articles
Contact Us
Filters
Showing results (101-110 of 129) with videos related to
Page
of 13
Sort By:
The Biochemical Journal
|
April 19, 2000
Polyamines directly induce release of cytochrome c from heart mitochondria
C Stefanelli, I Stanic', M Zini, et al.
European Journal of Endocrinology
|
November 1, 1996
Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males
A Colao, M De Rosa, F Sarnacchiaro, et al.
Metabolism: Clinical and Experimental
|
August 1, 1996
Cardiovascular aspects in acromegaly: effects of treatment
G Lombardi, A Colao, D Ferone, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1994
CV 205-502 in the treatment of tumoral and non-tumoral hyperprolactinemic states
B Merola, F Sarnacchiaro, A Colao, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 20, 1998
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males
C Di Somma, A Colao, A Di Sarno, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
September 1, 1994
Positive response to compound CV 205-502 in hyperprolactinemic patients resistant to or intolerant of bromocriptine
B Merola, F Sarnacchiaro, A Colao, et al.
British Journal of Cancer
|
November 21, 2007
Phase II study of sequential chemotherapy with docetaxel-estramustine followed by mitoxantrone-prednisone in patients with advanced hormone-refractory prostate cancer
L Galli, A Fontana, C Galli, et al.
Molecular Aspects of Medicine
|
January 1, 1997
The two-electron quinone reductase DT-diaphorase generates and maintains the antioxidant (reduced) form of coenzyme Q in membranes
R E Beyer, J Segura-Aguilar, S di Bernardo, et al.
Oral Diseases
|
March 1, 2024
Anti-resorptive therapy and MRONJ. A survey of the Italian Society of Periodontology and Implantology
L Landi, G Oteri, L Barbato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 15, 2010
Consequences of targeted treatments for second-line therapy
E De Maio, C Tibaldi, A D'Incecco, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 129) with videos related to
Sort By:
Page
of 13
The Biochemical Journal
|
April 19, 2000
Polyamines directly induce release of cytochrome c from heart mitochondria
C Stefanelli, I Stanic', M Zini, et al.
European Journal of Endocrinology
|
November 1, 1996
Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males
A Colao, M De Rosa, F Sarnacchiaro, et al.
Metabolism: Clinical and Experimental
|
August 1, 1996
Cardiovascular aspects in acromegaly: effects of treatment
G Lombardi, A Colao, D Ferone, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1994
CV 205-502 in the treatment of tumoral and non-tumoral hyperprolactinemic states
B Merola, F Sarnacchiaro, A Colao, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 20, 1998
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males
C Di Somma, A Colao, A Di Sarno, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
September 1, 1994
Positive response to compound CV 205-502 in hyperprolactinemic patients resistant to or intolerant of bromocriptine
B Merola, F Sarnacchiaro, A Colao, et al.
British Journal of Cancer
|
November 21, 2007
Phase II study of sequential chemotherapy with docetaxel-estramustine followed by mitoxantrone-prednisone in patients with advanced hormone-refractory prostate cancer
L Galli, A Fontana, C Galli, et al.
Molecular Aspects of Medicine
|
January 1, 1997
The two-electron quinone reductase DT-diaphorase generates and maintains the antioxidant (reduced) form of coenzyme Q in membranes
R E Beyer, J Segura-Aguilar, S di Bernardo, et al.
Oral Diseases
|
March 1, 2024
Anti-resorptive therapy and MRONJ. A survey of the Italian Society of Periodontology and Implantology
L Landi, G Oteri, L Barbato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 15, 2010
Consequences of targeted treatments for second-line therapy
E De Maio, C Tibaldi, A D'Incecco, et al.
Page
of 13